HPV Co-Testing vs Pap Alone — What's the Difference?
One test looks for a cause, the other for a consequence. Run separately they answer different questions; run together they answer a third one that neither can reach on its own.
Short answer. A Pap alone examines the cells and reports what they look like today. Co-testing adds an HPV test, so you learn both whether the cells have changed and whether the virus that could change them is present. Co-testing is more sensitive and allows longer safe intervals when both results are negative.
What each test is actually asking
The two tests are usually taken from the same sample, at the same appointment, with the same brush. That physical similarity hides how different the questions are.
Cytology asks a pathologist to look at the cells and judge whether their nuclei, shape and staining appear normal. It is an assessment of the tissue's current state, made by human judgement.
The HPV test asks a machine whether the genetic material of a high-risk viral type is present in the sample. It is a yes-or-no molecular result, not a judgement, and it says nothing about the cells.
Source: National Cancer Institute — cervical cancer screening tests and how they differ.
How they compare
Each has a genuine advantage over the other, which is why neither has simply replaced its counterpart.
| Cytology (Pap) | HPV test | |
|---|---|---|
| What it detects | Changed cells | The virus that causes them |
| How it is read | By a pathologist, with judgement involved | By a machine, with a binary result |
| Sensitivity for high-grade change | Moderate — misses a proportion | High |
| Specificity | Higher — an abnormal smear usually means something | Lower — most positives are transient infections |
| Reproducibility | Varies, particularly at the borderline grades | Consistent |
| Best at | Confirming that change exists now | Ruling out that anything is likely to develop |
The final row is the key to understanding why they are combined. Cytology is good at finding something; the HPV test is exceptionally good at reassuring when it is negative. A woman who is negative on both can safely wait years.
What co-testing adds
The four possible combinations each mean something distinct, and this is the real value of running both.
| Result | Interpretation | Usual action |
|---|---|---|
| Both negative | Very low risk; the strongest reassurance available | Extended interval, often five years |
| HPV positive, cytology normal | Virus present, cells not yet affected | Repeat in 12 months, or colposcopy if 16 or 18 |
| HPV negative, cytology abnormal | Usually a benign or reactive change | Often repeat rather than colposcopy, depending on grade |
| Both positive | Virus and cell change together | Colposcopy |
The third row is where co-testing prevents most unnecessary intervention. An ASCUS smear with a negative HPV test carries a risk of underlying high-grade change comparable to a normal smear — information a Pap alone could never provide.
Also useful: What Does ASCUS on a Pap Smear Mean?
Why intervals lengthen with co-testing
This is the part that unsettles people: being told they need testing less often after a more thorough test. The logic is sound and worth following.
A negative HPV result means the cause of cervical cancer is not present. Since the disease cannot develop without persistent high-risk infection, and since acquiring an infection and progressing to high-grade change takes years, a woman negative on both tests has a very long safe window ahead of her.
Cytology alone cannot support that conclusion, because it can only report what the cells look like today — it says nothing about whether a cause is present. Hence the shorter interval when it is used alone.
Where cytology alone still has a place
It has not been abandoned, and there are sound reasons for that.
In younger women — typically under twenty-five or thirty, depending on the country — HPV positivity is common and transient, running at around 20–25% in the early twenties. Testing for the virus in that group would identify enormous numbers of infections destined to disappear and lead to procedures on cervixes that never needed them.
Cytology also remains the tool that assesses the cells directly, which matters in situations where the HPV result is uninformative — glandular abnormalities, for instance, where a proportion of endometrial pathology has no relationship to the virus at all.
Second opinion. If you are unsure which tests were performed on your sample, or what the combination means, you can request an online second opinion for HPV, smear and colposcopy.
What to check on your own report
Reports vary and the wording is not always transparent. Look for four things.
Whether an HPV test was performed at all, or only cytology. Whether the HPV result distinguishes 16 and 18 from the pooled other high-risk types — this single detail changes what should happen next. What the cytology says in its own terms, using the standard categories rather than a summary word. And whether the sample was reported as satisfactory, since an inadequate sample is not a negative one.
If any of those is missing and you are being managed on the basis of the result, it is reasonable to ask. In our practice in Türkiye we go through all four with the patient rather than summarising the report into a single reassuring sentence.
Read next: What Is HPV Primary Screening?
Source: ACOG — cervical cancer screening: co-testing and interval guidance.
Co-testing versus Pap alone — questions and answers
Cytology examines the cells and reports what they look like today, judged by a pathologist. The HPV test detects the genetic material of a high-risk viral type and returns a binary result, saying nothing about the cells themselves.
Neither, and that is why they are combined. Cytology is better at confirming that change exists now, while the HPV test is exceptionally good at reassuring when negative — which is what allows a longer interval.
Because a negative HPV result means the cause of cervical cancer is not present. Since the disease cannot develop without persistent high-risk infection, and progression takes years, a woman negative on both has a very long safe window.
That combination usually points to a benign or reactive change such as inflammation or atrophy. Borderline cells alongside a negative virus result carry about as much risk as a normal smear does — which is information cytology alone could never supply.
Because positivity is common and transient at that age, running at around 20 to 25% in the early twenties. Testing that group would identify large numbers of infections destined to disappear and lead to procedures on cervixes that never needed them.
Usually yes — the same brush and the same sample can be used for both, so it does not mean two appointments or two examinations.
Whether an HPV test was done at all, whether it distinguishes types 16 and 18 from the pooled result, what the cytology says in standard terms, and whether the sample was reported as satisfactory rather than inadequate.
Patients often assume the HPV test replaced the smear, and then find it strange that I still want both. The way I put it is that one tells me whether there is a fire and the other whether there is a match in the room. Neither answer is much use without the other, and together they let me leave someone alone for five years with a clear conscience.
